Autopsy report · NCT03700892
In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense
Cause of deathStaffing, sites or logistics, also safety
“Covid-19 has been shown to increase risk associated with vaping. To increase participant safety and use real world vaping habits, the investigators plan to continue studying vaping effects on the airways in an observational format.”
Life of this trial
- Ran for about 1 year 4 months before it stopped.
- 19 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Conditions
- Smoking; Healthy
- Interventions
- Cinnamaldehyde e-liquid; PG/VG e-liquid
- Participants
- 19
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.